| Bioactivity | Docosahexaenoyl glycine is a PUFA analogue. Docosahexaenoyl glycine has activating effects on IKs?channels?and restore the function of IKs?channels with LQT1 mutation[1]. |
| Target | IC50: IKs?Channel |
| Name | Docosahexaenoyl glycine |
| CAS | 132850-40-9 |
| Formula | C24H35NO3 |
| Molar Mass | 385.54 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Mark A Skarsfeldt, et al. Polyunsaturated fatty acid-derived IKs channel activators shorten the QT interval ex-vivo and in-vivo. Acta Physiol (Oxf). 2020 Aug;229(4):e13471. |
Docosahexaenoyl glycine
CAS: 132850-40-9 F: C24H35NO3 W: 385.54
Docosahexaenoyl glycine is a PUFA analogue. Docosahexaenoyl glycine has activating effects on IKs?channels?and restore t
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.